M E Mbizvo1, S E Musya, B Stray-Pedersen, Z Chirenje, A Hussain. 1. Institute of General Practice and Community Medicine, Department of International Health, University of Oslo, Postboks 1130, Blindern 0317, Oslo. elizabethmbizvo@hotmail.com
Abstract
OBJECTIVES: To determine the prevalence of bacterial vaginosis and to identify risk factors associated with this condition among urban women in Harare, Zimbabwe. DESIGN: A cross sectional study. MAIN OUTCOME MEASURES: Prevalent bacteria vaginosis (BV), HIV and intravaginal practices. SETTING: Urban primary health care clinics in Harare. SUBJECTS: 177 pregnant and 212 non pregnant women attending mother and child health care clinics. INTERVENTIONS: The women were recruited, counselled, interviewed, examined and tested for reproductive tract infections including HIV. Those with reproductive tract infections were given free treatment. RESULTS: The prevalence of bacterial vaginosis was 36% among HIV seropositive women and 26% among those seronegative. Fifty one per cent of the women practiced intravaginal cleansing, while another 28% reported use of intravaginal herbs. Women reporting intravaginal cleansing and/or use of intravaginal herbs were more likely to have bacterial vaginosis (OR 6.2 CI 3.6 to 10.7) and (OR 1.5 CI 1.1 to 2.5) and to be HIV seropositive (OR 1.8 CI 1.2 to 2.8) and (OR 1.8 CI 1.1 to 2.9) respectively. Other factors associated with bacterial vaginosis were malodorous vaginal discharge (OR 5.8 CI 2.9 to 10.7), genital warts (OR CI 3 CI 1.1 to 10.1) and Trichomonas vaginalis (OR 25.5 CI 11.6 to 56.7). CONCLUSIONS: BV was shown to be a common condition among the women the majority of whom indulged in intravaginal practices. HIV infection among women with BV and those that practiced intravaginal cleansing and/or use of herbs was significantly higher. Although causal relationship could not be established in this cross sectional study the results suggest that BV may facilitate HIV infection and we suggest the inclusion of information regarding risks associated with intravaginal practices into health education information disseminated to women.
OBJECTIVES: To determine the prevalence of bacterial vaginosis and to identify risk factors associated with this condition among urban women in Harare, Zimbabwe. DESIGN: A cross sectional study. MAIN OUTCOME MEASURES: Prevalent bacteria vaginosis (BV), HIV and intravaginal practices. SETTING: Urban primary health care clinics in Harare. SUBJECTS: 177 pregnant and 212 non pregnant women attending mother and child health care clinics. INTERVENTIONS: The women were recruited, counselled, interviewed, examined and tested for reproductive tract infections including HIV. Those with reproductive tract infections were given free treatment. RESULTS: The prevalence of bacterial vaginosis was 36% among HIV seropositivewomen and 26% among those seronegative. Fifty one per cent of the women practiced intravaginal cleansing, while another 28% reported use of intravaginal herbs. Women reporting intravaginal cleansing and/or use of intravaginal herbs were more likely to have bacterial vaginosis (OR 6.2 CI 3.6 to 10.7) and (OR 1.5 CI 1.1 to 2.5) and to be HIV seropositive (OR 1.8 CI 1.2 to 2.8) and (OR 1.8 CI 1.1 to 2.9) respectively. Other factors associated with bacterial vaginosis were malodorous vaginal discharge (OR 5.8 CI 2.9 to 10.7), genital warts (OR CI 3 CI 1.1 to 10.1) and Trichomonas vaginalis (OR 25.5 CI 11.6 to 56.7). CONCLUSIONS: BV was shown to be a common condition among the women the majority of whom indulged in intravaginal practices. HIV infection among women with BV and those that practiced intravaginal cleansing and/or use of herbs was significantly higher. Although causal relationship could not be established in this cross sectional study the results suggest that BV may facilitate HIV infection and we suggest the inclusion of information regarding risks associated with intravaginal practices into health education information disseminated to women.
Authors: Margaret P Kasaro; Marla J Husnik; Benjamin H Chi; Cheri Reid; Tsitsi Magure; Bonus Makanani; Tchangani Tembo; Gita Ramjee; Lisa Maslankowski; Lorna Rabe; M Brad Guffey Journal: Int J STD AIDS Date: 2016-07-10 Impact factor: 1.359
Authors: John Kinuthia; Barbra A Richardson; Alison L Drake; Daniel Matemo; Jennifer A Unger; Raymond S McClelland; Grace John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2017-02-01 Impact factor: 3.731
Authors: Abigail Norris Turner; Charles S Morrison; Marshall W Munjoma; Precious Moyo; Tsungai Chipato; Janneke H van de Wijgert Journal: Infect Dis Obstet Gynecol Date: 2010-08-24
Authors: P Madhivanan; K Krupp; V Chandrasekaran; C Karat; A Arun; C R Cohen; A L Reingold; J D Klausner Journal: Indian J Med Microbiol Date: 2008 Apr-Jun Impact factor: 0.985
Authors: Mark A Klebanoff; Tonja R Nansel; Rebecca M Brotman; Jun Zhang; Kai-Fun Yu; Jane R Schwebke; William W Andrews Journal: Sex Transm Dis Date: 2010-02 Impact factor: 2.830
Authors: Francisca Nana-Aba McCarthy; Nicholas Israel Nii-Trebi; Billal Obeng Musah; Richard Harry Asmah Journal: BMC Womens Health Date: 2015-06-04 Impact factor: 2.809